🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pancreatic Cancer Resectable

Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer NCT07529626n/a3 sites📍 Changsha📍 Shanghai📍 Xi’an Shanghai Zhongshan Hospital ctDNA Assay in Patients With Resectable Pancreatic Cancer NCT05052671n/a2 sites📍 Oklahoma City📍 Tulsa University of Oklahoma Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients NCT06730009Phase 1, Phase 21 site📍 Tainan Medigen Biotechnology Corporation · Tests: SLOG + Allogeneic NK cell, SLOG chemotherapy CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites📍 Denver📍 Chicago📍 Grand Rapids Context Therapeutics Inc. · Tests: CT-95 Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer NCT04969731Phase 31 site📍 Seoul GC Cell Corporation · Tests: Immuncell-LC, Gemcitabine Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula NCT05116072Phase 1, Phase 21 site📍 Lille University Hospital, Lille · Tests: total pancreatectomy, intraportal islet autotransplantation DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer NCT07705919Phase 1, Phase 21 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Computed Tomography, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Fluorouracil, Gadoli… Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC NCT06714604Phase 31 site📍 Gothenburg Sahlgrenska University Hospital · Tests: FOLFIRINOX or gemcitabine-nab-paclitaxel, FOLFIRINOX or gemcitabine-nab-paclitaxel Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer NCT06326736EARLY Phase 11 site📍 Nanjing Jinling Hospital, China · Tests: Surgery, Camrelizumab, SJ-Neo006, Gemcitabine+Abraxane Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer NCT07539155Phase 1, Phase 21 site📍 Little Rock University of Arkansas · Tests: Intratumoral MMR Injection Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial) NCT05298722NA8 sites📍 Ghent📍 Dendermonde📍 Eeklo University Hospital, Ghent · Tests: Imaging analysis of CT-scan and MRI with radiomics and genetic analysis of peripheral blood samples and questionnaires. Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer NCT07235930Phase 31 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Sequential AG and mFOLFOX in Combination With Serplulimab and Bevacizumab, AG chemotherapy Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5) NCT06384560Phase 1, Phase 24 sites📍 Amsterdam📍 Maastricht📍 Nieuwegein Amsterdam UMC, location VUmc · Tests: Pembrolizumab, Folfirinox, SABR Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment NCT06574620NA1 site📍 Vancouver British Columbia Cancer Agency · Tests: Genetic testing, Optional biopsy, Tissue collection Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma NCT06582017Phase 111 sites📍 Los Angeles📍 Los Angeles📍 Los Angeles Nammi Therapeutics Inc · Tests: QXL138AM Injection every 2 weeks by IV Infusion Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic Cancer NCT07575191Phase 1, Phase 21 site📍 Solna Smartwise Sweden AB · Tests: Gemcitabine, Extroducer Infusion Catheter System Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy NCT06935448n/a1 site📍 Larissa University of Thessaly · Tests: enhanced recovery after surgery Adjuvant Pancreatic Therapy Guided by MRD NCT06966440NA1 site📍 Shanghai Ruijin Hospital · Tests: circulating tumor DNA (ctDNA)-based MRD, adjuvant chemotherapy regimens NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) NCT05529940Phase 32 sites📍 Seoul📍 Seoul Seoul National University Hospital · Tests: Folfirinox Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer NCT06605430Phase 21 site📍 Saint Louis Park HealthPartners Institute · Tests: Medical Cannabis The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer NCT06368063Phase 41 site📍 Xi'an Xi'an Jiaotong University · Tests: Huaier granule, chemotherapy drugs Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer NCT06782932Phase 1, Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: AGEN2373, Balstilimab, Cyclophosphamide, GVAX, AGEN2373 (RP2D) Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer NCT03492671Phase 21 site📍 Loma Linda Loma Linda University · Tests: Gemcitabine 1000 mg, nab-paclitaxel, Stereotactic Body Radiation Therapy A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer NCT07481383Phase 12 sites📍 Ann Arbor📍 Morgantown Continuity Biosciences, LLC · Tests: ACT Implantable Iontophoresis Chemotherapy Delivery Device with Gemcitabine (ACT-IOP-003) Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer NCT06496373EARLY Phase 11 site📍 Shanghai Ruijin Hospital · Tests: Fixed neoantigen tumor vaccine, personalized neoantigen tumor vaccine, PD-1 inhibitor Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas NCT02598349Phase 24 sites📍 Little Rock📍 Jacksonville📍 Warrenville Proton Collaborative Group · Tests: Proton Radiation, Capecitabine, Surgical resection Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery NCT06731998NA1 site📍 Pittsburgh Allegheny Singer Research Institute (also known as Alleghen… · Tests: Local Anesthesia, Laparoscopic Transversus Abdominis Plane block mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients NCT04084496Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Folfirinox DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer NCT06173310NA2 sites📍 Indianapolis📍 Columbus Ohio State University · Tests: Point-of-care Portable Perfusion Phantom (P4) Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer NCT07436741Phase 31 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: surufatinib + gemcitabine + nab-paclitaxel, gemcitabine + nab-paclitaxel
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy